Gadolinium MRI Poisoning Investigation


Gadolinium Poisoning MRI
July 18, 2018 Categories: FDA updates, Product Liability

Pin It

Gadolinium MRI Poisoning Investigation

The FDA issued a safety alert in December 2017, stating that some patients who received a gadolinium-based contrast during an MRI procedure, may retain the gadolinium in their bodies for months, or even for years, causing serious side effects.

Gadolinium is commonly used in MRIs to enhance the images the test provides. Gadolinium is a heavy metal and its magnetic qualities improve the visualization of organs, blood vessels, and tissues. Gadolinium contrast enhances an ability to diagnose cancer, infections, bleeding, and other serious conditions.

The FDA said that gadolinium toxicity can cause a rare condition known as nephrogenic systemic fibrosis (NSF) that occurs in patients with pre-existing kidney problems.
Another concern is that the FDA has also received reports of multi-organ system failure in patients with normal kidney function.

The FDA is requiring a new class warning and other safety measures for all gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (or MRI) concerning gadolinium remaining in patients’ bodies, including the brain, for months to years after receiving these drugs.

U.S. Food and Drug Administration

Your Comment

Recent Updates

It has been a few years since Roundup®, a product of Monsanto, was reportedly linked to a serious disease called non-Hodgkin lymphoma. People who worked with the weed-killer Roundup® across the United States were exposed to glyphosate, which is the main ingredient in the most popular herbicide in the country. Case of DeWayne Johnson against...

July 25, 2018

The FDA issued a safety alert in December 2017, stating that some patients who received a gadolinium-based contrast during an MRI procedure, may retain the gadolinium in their bodies for months, or even for years, causing serious side effects. Gadolinium is commonly used in MRIs to enhance the images the test provides. Gadolinium is a...

July 18, 2018

Valsartan is mainly used for treatment of high blood pressure, congestive heart failure, and after a heart attack. The FDA has announced a recall of several drugs that contain the heart drug valsartan because a possible carcinogen NDMA (N-Nitrosodimethylamine) that was found in the recalled products. NDMA, which was found in the valsartan products, could...

July 17, 2018